5-(Perylen-3-ylethynyl)uracil Derivatives Inhibit Reproduction of Respiratory Viruses.
Y V Nikolayeva1, E A Ulashchik2, E V Chekerda1
1Smorodintsev Research Institute of Influenza, 197376 St. Petersburg, Russia.
Russian Journal of Bioorganic Chemistry
|August 25, 2020
Summary
A novel compound, 5-(perylen-3-ylethynyl)uridine, effectively inhibits replication of key respiratory viruses like influenza A virus (IVA), parainfluenza virus (PIV-3), and respiratory syncytial virus (RSV) in cell cultures.
Area of Science:
- Organic Chemistry
- Virology
- Antiviral Drug Discovery
Background:
- Respiratory viruses pose a significant global health burden.
- Development of novel antiviral agents is crucial for managing respiratory diseases.
- Perylene derivatives have shown potential in various biological applications.
Purpose of the Study:
- To synthesize and characterize 5-(perylen-3-ylethynyl)uridine.
- To evaluate the antiviral activity of this compound against major respiratory pathogens.
- To compare its efficacy with related perylene-nucleoside analogs.
Main Methods:
- Chemical synthesis of 5-(perylen-3-ylethynyl)uridine.
- Cell culture-based assays to assess viral replication inhibition.
- Analysis of related compounds including 5-(perylen-3-ylethynyl)-2'-deoxy-uridine and others.
Main Results:
- Successful synthesis of 5-(perylen-3-ylethynyl)uridine.
- Demonstrated significant inhibition of influenza A virus (IVA) replication.
- Showed notable efficacy against type 3 parainfluenza virus (PIV-3) and human respiratory syncytial virus (RSV).
Conclusions:
- 5-(perylen-3-ylethynyl)uridine is a potent inhibitor of key respiratory virus replication.
- This compound represents a promising candidate for the development of new antiviral therapies.
- Further research into its mechanism of action and in vivo efficacy is warranted.
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
750
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
750
Drugs Used in Upper Respiratory Disorders: Overview
512
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
512
Viruses with RNA Genomes
531
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
531
Upper Respiratory Drugs: Decongestants
627
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
Most decongestants are readily available over-the-counter in...
627
Eukaryotic Transcription Inhibitors
10.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.8K
Upper Respiratory Drugs: First and Second-Generation Antihistamines
772
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
772


